Wells Fargo Initiates Coverage On Ironwood Pharmaceuticals With Overweight Rating, Announces Price Target of $20
Wells Fargo Initiates Coverage On Ironwood Pharmaceuticals With Overweight Rating, Announces Price Target of $20
富国银行以增持评级启动对Ironwood Pharmicals的报道，宣布目标股价为20美元
Wells Fargo analyst Mohit Bansal initiates coverage on Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Overweight rating and announces Price Target of $20.
富国银行分析师莫希特·班萨尔以增持评级开始对艾恩伍德制药（纳斯达克股票代码：IRWD）进行报道，并宣布目标股价为20美元。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。